IQVIA Holdings, Inc. Common Stock (IQV)
272.90
-0.70 (-0.26%)
NYSE · Last Trade: Oct 27th, 4:14 PM EDT
News & Press Releases
What IQVIA (IQV) Said on Its Q3 Earnings Callmarketbeat.com
IQVIA (NYSE:IQV) reported third-quarter results that exceeded the high end of its guidance ranges, supported by accelerating organic growth in its Commercial Solutions and R&D Solutions businesses, higher clinical win rates and strong free cash flow.
Revenue totaled $4.43 billion, up 8.0% year
Via MarketBeat · October 27, 2026
IQVIA (IQV) Q3 2026 Earnings Call Transcriptfool.com
Revenue hit $4.4 billion with 8% growth; net new bookings surged 15% year over year.
Via The Motley Fool · October 27, 2026
S&P 500 Premarket Movers: Royal Caribbean, S&P Global Gain; Xylem, Sherwin-Williams Fallchartmill.com
Via Chartmill · October 27, 2026
IQVIA HOLDINGS INC (NYSE:IQV) Sets Up for Breakout With Strong Technical Ratingschartmill.com
Via Chartmill · October 20, 2026
IQVIA (NYSE:IQV) Nears Breakout With 10/10 Technical Strength and 9/10 Setupchartmill.com
Via Chartmill · September 23, 2026
IQVIA’s (NYSE:IQV) Q3 2026: beats on revenue
Clinical research company IQVIA (NYSE: IQV) reported Q3 2026 results exceeding the market’s revenue expectations, with revenue up 8% year on year to $4.43 bi...
Via StockStory · October 27, 2026
IQVIA Reports Third-Quarter 2026 Results
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2026.
By IQVIA Holdings Inc. · Via Business Wire · October 27, 2026
IQVIA (IQV) Q3 earnings report preview: what to look for
Clinical research company IQVIA (NYSE: IQV) will be reporting results this Tuesday before market open. Here’s what to expect. IQVIA beat analysts’ revenue ex...
Via StockStory · October 25, 2026
1 Large-Cap Stock to Research Further and 2 We Avoid
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
Via StockStory · October 19, 2026
3 Low-Volatility Stocks with Questionable Fundamentals
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...
Via StockStory · October 16, 2026
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034 New York, NY – October 15, 2026 – Artificial intelligence is starting to change the way healthcare works, and the opportunity is getting harder to ignore. From spotting diseases […]
Via FinancialNewsMedia · October 15, 2026
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
AI-powered diagnostics, drug discovery and intelligent medical technology are opening the door to a potentially massive global market projected to reach $1 trillion by 2034
By FN Media · Via GlobeNewswire · October 15, 2026
IQVIA Selects Veeva Clinical Operations Applications
IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously announced EDC partnership.
By IQVIA · Via Business Wire · October 13, 2026
IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Life Science ModelsTM to help predict clinical trial outcomes.
By IQVIA · Via Business Wire · October 7, 2026
IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 introduced IQVIA Explorer™ to help customers make better-informed commercial decisions.
By IQVIA · Via Business Wire · October 7, 2026
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via StockStory · October 6, 2026
IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2026 financial results before the market opens on Tuesday, October 27, 2026. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at: http://ir.iqvia.com.
By IQVIA · Via Business Wire · September 29, 2026
IQVIA Announces Pricing of Senior Notes
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering.
By IQVIA Holdings Inc. · Via Business Wire · September 9, 2026
IQVIA Announces Offering of Senior Notes
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the “Notes”).
By IQVIA Holdings Inc. · Via Business Wire · September 9, 2026
IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?
The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thank...
Via StockStory · September 8, 2026
1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · September 4, 2026
IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.
By IQVIA · Via Business Wire · September 3, 2026
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind...
Via StockStory · August 30, 2026
IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution.
By IQVIA · Via Business Wire · August 27, 2026
2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are...
Via StockStory · August 25, 2026